AS THE Republican Party continues their campaign against Obamacare, the Obama administration keeps expanding preventative coverage for women who previously had no recourse. Coverage of chemoprevention drugs like tamoxifen and raloxifene is a remarkable effort by the Administration. Breast cancer impacts women in very real ways, when heredity is the foundation for many who battle the disease.
An excerpt from Dr. Jill Biden’s post on the announcement Thursday.
That is why I am so pleased that today the Administration is making clear that most health insurance plans must soon cover chemoprevention medications like tamoxifen and raloxifene that can reduce the risk of breast cancer for women who have an increased chance of developing the disease. In addition, these health plans will have to cover the medications at no cost to these women.
Women who are at high risk of developing breast cancer face many questions. Now, if their doctor recommends that the benefits of this treatment outweigh the risks, one question women across the country won’t have to ask is whether they can afford it.
This is just one more way the Affordable Care Act is helping fight breast cancer. Already, the ACA ensures that about 47 million women have access to free mammograms every year or two, that insurance companies can no longer deny coverage or increase premiums due to pre-existing conditions like breast cancer, and new health plans can no longer set an annual or lifetime cap on someone’s health insurance benefits – meaning women diagnosed with breast cancer will not max out their insurance benefits while seeking treatment.